Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02926768
Title Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Checkpoint Therapeutics, Inc.
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

CK-101

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.